Treatment of a variety of cutaneous fungal infections, including tinea pedis (athlete's foot), tinea cruris (jock itch), tinea corporis (ringworm).
Affects the synthesis of the fungal cell wall, allowing leakage of cellular contents.
Decrease in symptoms of fungal infection.
Absorption: Absorption through intact skin is minimal.
Distribution: Distribution after topical administration is primarily local.
Metabolism and Excretion: Systemic metabolism and excretion not known following local application.
Half-life: Not applicable.
Use Cautiously in:
Local: burning, itching, local hypersensitivity reactions, redness, stinging
* CAPITALS indicate life-threatening.
Underline indicate most frequent.
Topical (Adults and Children > 2 yr): Apply twice daily. Treat patients with tinea cruris for 2 wk and patients with tinea pedis or tinea corporis for 4 wk.
Cream: 2%Rx, OTC
Lotion powder: 2%OTC
Spray liquid: 2%OTC
Spray powder: 2%OTC
In Combination with: zinc oxide (Vusion)Rxcombination drugs.
Consult health care professional for proper cleansing technique before applying medication.
Decrease in skin irritation and resolution of infection. Early relief of symptoms may be seen in 2–3 days. For tinea cruris and tinea corporis, 2 wk are needed, and for tinea pedis, therapeutic response may take 3–4 wk. Recurrent fungal infections may be a sign of systemic illness.
Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Complete Product Information.